Information is needed on long-term functional results, sequelas, and outcome predictors for laparoscopic ventral mesh rectopexy.
L aparoscopic ventral mesh rectopexy (LVMR) has evolved to become the treatment of choice for external rectal prolapse (ERP) in Europe. 1 LVMR is also increasingly used to treat posterior pelvic floor dysfunction (pPFD), such as symptomatic internal rectal prolapse (IRP), enterocele, and complex rectocele, where it has shown improved short-and intermediate-term functional results. [2] [3] [4] [5] [6] LVMR for ERP is associated with low morbidity and a recurrence rate of 1.5% to 9.4%. [7] [8] [9] [10] [11] [12] Long-term improvement in function and quality of life (QoL) has been shown. 9 However, the use of LVMR for IRP with obstructive defecation symptoms is still under debate. 13 The use of surgical mesh to treat pelvic organ prolapse has raised some concerns. Recently, a large multicenter study found a 2% mesh erosion rate postrectopexy. The authors recommended an international ventral mesh registry to monitor mesh problems, allowing the assessment of whether the mesh type has any effect on functional outcomes or the need for revisional surgery for other reasons. 14 In addition to the use of different types of mesh prostheses, since D'Hoore et al 7 first described ventral mesh rectopexy in 2004, reports on LVMR procedures have described a variety of operative modifications or details. 5, [15] [16] [17] The literature provides no data to indicate the gold standard for the mesh prosthesis type, shape, fixation method, or optimal number of sutures. 1, 12 Information on factors that could predict successful or adverse operative and functional outcomes is needed for appropriate patient selection and detailed technical performance of the ventral rectopexy procedure.
The aim of this multicenter registry and questionnaire study was to evaluate the clinical outcomes, complications, and long-term functional outcomes and recurrence in a large cohort of patients. The possible relationships among patient characteristics, indications and operative technical details, and patient-reported functional outcomes were assessed using multivariate analysis.
PATIENTS AND METHODS

Study Population and Data Collection
All of the consecutive patients who underwent LVMR for ERP or symptomatic IRP since the introduction of the operative method in 2 university hospitals (Oulu University Hospital and Helsinki University Hospital) and 2 central hospitals (Central Finland Central Hospital and Päijät-Häme Central Hospital) in 2005 to 2013 were included in the study. Operative and clinical data from the prospectively collected registry files of each institution were collated into 1 database for analysis; additional data were retrieved from the patient medical charts. The indications for the LVMR procedure and clinical follow-up were determined according to the practice of the individual center. The study received ethical approval from the Oulu University Hospital Ethics Committee.
Surgical Technique
In each hospital, experienced colorectal surgeons performed the operations. The surgical technique primarily followed the details described by D'Hoore and colleagues, 7, 15 with minor modifications to the original procedure by some surgeons. The pelvic peritoneum was opened with diathermy scissors or with a Harmonic Scalpel (Johnson & Johnson, Ethicon Endosurgery, Somerville, NJ). Dissection toward the levator level was performed only anterior to the rectum, thereby preserving the lateral ligaments and sparing the hypogastric and parasympathetic nerves. The mesh was sutured as distally as possible onto the anterior rectal wall using interrupted seromuscular nonabsorbable sutures (2-0 Ethibond, Ethicon Endosurgery) and to the apex of the vagina in women. As a variation of the original operative technique, some surgeons sutured the mesh to the levator muscle or through the pelvic floor with either absorbable or nonabsorbable sutures (2-0 Polysorb, Medtronic, Dublin, Ireland; Vicryl, Ethicon Endosurgery; or Ethibond), as described previously. 17 The upper part of the mesh was fixated to the sacral promontory using spiral attachments (Pro-Tack TM Fixation Device, Medtronic). The peritoneum was closed over the mesh with intermittent or continuous sutures. For the robotic operations with the da Vinci Surgical System (Intuitive Surgical Inc, Sunnyvale, CA), side docking with 5 trocar placements was used. Perioperative care was conducted per the enhanced recovery after surgery protocol.
Follow-Up and Questionnaires
All patients alive at follow-up were sent a questionnaire that included the Wexner Continence Grading Scale 18 for incontinence symptoms and obstructive defecation score (ODS) 19 for constipation/obstructed defecation symptoms. Patients reported possible discomfort experienced because of the incontinence and obstructed defecation/ constipation symptoms with a 100-mm visual analog scale (VAS; from no discomfort to great discomfort). The change before and after the operation in bowel/defecatory symptoms and the effect of symptoms on QoL were also reported using a simple VAS scale (from much worse to much better). Questions on the appearance of de novo symptoms during the first 6 months postoperation specified urinary incontinence, incomplete bladder emptying, pelvic pain, the loss of sensation for defecation, and urge; the patients were free to comment on additional symptoms. Another item on the possible effects resulting from the operation was included concerning the impact on sexual function and symptoms that were present before the operation (urinary incontinence, bladder emptying, pelvic pain, and pelvic organ prolapse in women). The preoperative-postoperative change regarding each symptom was assessed using a VAS (from much worse to much better). Finally, the patients were asked whether they were satisfied with the operation results (yes, no, or cannot say).
Outcome Parameters
Data were collected for multivariate analysis on the following patient-related characteristics: age; sex; BMI; ASA classification; number of medical conditions; previous abdominal, pelvic, and prolapse surgery; previous hysterectomy; previous posterior colporrhaphy; indications/ symptoms for the operation; and the anatomic diagnosis of a pelvic floor defect. The operative technical details for multivariate analysis included the technique (laparoscopic/robotic) and instrument used for dissection, mesh type and fixation method to the pelvic floor, suturing method and number of sutures used, and whether vaginal sutures were applied, as well as the occurrence of complications. The clinical outcome parameters studied were the operative time, complications and conversion, length of stay, recurrence, any revisional surgery, and surgery for complications. The Wexner score was used for the evaluation of incontinence (range, 0-20, with 20 representing complete incontinence and >9 regarded as disturbing incontinence symptoms). Constipation/obstructed defecation was assessed with the ODS (range, 0-40, with a score >20 regarded as disturbing constipation). Patients marking a point (from much worse to much better) at 61 to 100 mm on the VAS scale were considered to have experienced a change for the better; the effect of the operation on symptom relief was therefore successful.
Statistical Analysis
Summary statistics are presented as mean and SD unless stated otherwise. Student t test (continuous variables) or ANOVA (continuous variables, >2 groups) and Pearson χ 2 test (categorical variables) were used for between-group analyses. Comparisons between preoperative and follow-up measurements were analyzed using the paired-samples t test. A multivariate logistic regression model was generated to assess possible risk factors for symptom relief or symptom-related QoL. Variables with p < 0.3 or clinical interest were included in the analyses. A variable was left in the model if p value was <0.05 or its influence on the log likelihood function was significant. Two-tailed p values are reported. Analyses were performed using SPSS for Windows (IBM SPSS Statistics for Windows, version 21.0, IBM Corp, Armonk, NY).
RESULTS
In all, 508 consecutive patients (481 women and 27 men) underwent LVMR or robotic ventral mesh rectopexy over an 8-year period in the 4 participating hospitals (Oulu = 124; Jyväskylä = 186; Lahti = 111; Helsinki = 87). Thirty-seven patients (7.3%) underwent reoperation for prolapse. Clinical follow-up information was available for 369 (72.6%) of 508 patients.
Patient demographics are presented in Table 1 . The main indications for LVMR were ERP in 286 (56%) and symptomatic IRP with/without an enterocele in 214 patients (42%). Of the IRP patients, 168 (79%) presented with obstructed defecation symptoms, 37 (17%) with incontinence symptoms, and 42 (20%) with combined symptoms. The median follow-up length was 44 months (range, 1-105 mo).
Operation Details and Complications
The operation details and additional combination procedures are summarized in Table 2 . Most mesh prostheses (426/508; 83.9%) were made of polyester. No biological grafts were implanted. Eighteen patients (3.5%) had additional procedures in combination with LVMR; these are listed in Table 2 . Conversion to laparotomy occurred in 7 operations and was attributed to intraoperative complications in 4 patients (3 = intraoperative bleeding; 1 = vaginal perforation). Fifty-eight patients (11.4%) faced complications, and the median length of stay was 4 days (range, <1-30 d).
Fifty-eight patients (11.4%) faced complications, and 7 (1.4%) complications were mesh related, with 5 mesh erosions to the vagina and 2 rectovaginal fistulas; these are listed in Table 3 . The median time from the operation to the identification of mesh erosion was 8.5 months (range, 2.0-29.0 mo). In 3 (60%) of 5 operations leading to mesh erosion, the vaginal wall was perforated and sutured intraoperatively; 1 patient had adhesive rectovaginal space after a previous posterior colporrhaphy and a stapled transanal rectal resection operation, and in 1 case the perioperative course was uneventful. In 2 of these patients, the mesh was resected transvaginally, and the defect was sutured without the need for additional intervention. One combined laparoscopic and transvaginal mesh removal was carried out after a failed transvaginal local resection. Two mesh removals needed laparotomy. The other was followed by an advancement flap-plasty reconstruction at 6 months postoperation, after which the patient underwent laparoscopic ventral rerectopexy 17 months after the primary operation. Mesh erosion reoccurred, and the mesh was removed during another relaparotomy. There was no postoperative 60-day mortality.
Long-Term Functional Outcomes and Recurrence
Forty one (8%) of 508 patients died during the followup time for reasons unrelated to the operative treatment. A total of 330 questionnaires were returned by the 467 patients alive at follow-up, giving a response rate of 70.7% and a response rate of 65.0% of all 508 patients.
The patient-reported functional outcomes are presented in Figure 1 , and the functional results per indication are shown in Table 4 . Seventy-six percent of patients experienced defecatory symptom relief postoperation, and ERP patients reported more symptom relief (85.9%) than IRP patients with/without an enterocele (68.4%; p < 0.001). The impact on symptomrelated QoL was positive in 73.9% of patients. A change for the better was seen in more ERP patients (84.9%) than in IRP plus enterocele (64.6%), IRP (65.5%), or isolated rectocele patients (71.4%; P<0.001). The mean Wexner scores were 7.0 (SD = 6.1) and 6.9 (SD = 5.6), and the mean ODSs were 9.7 (7.6 = SD) and 12.3 (8.0 = SD) for ERP and IRP patients. Discomfort levels experienced because of continuing incontinence and obstructed defecation symptoms were a median of 12 per 100 mm (1-60 mm, 25th and 75th percentiles) and 37 per 100 mm (11-80 mm, 25th and 75th percentiles).
Pre-existing urinary incontinence was reported by 148 (46%), bladder emptying problems by 123 (39%), feelings of pelvic organ bulging by 108 (36%), and pelvic pain by 150 patients (48%). Changes for the better in the pre-existing symptoms of urinary incontinence, bladder emptying problems, feelings of pelvic organ bulging, and pelvic organ pain were seen in 43%, 27%, 53%, and 49% of patients. The similarly assessed effect on sexual function was positive in 56% of patients.
De novo symptoms were reported by 124 patients (38.9%); the urge sensation was the most common, in 77 patients (24.3%), and this was more often reported by patients with IRP (49/166; 29.5%) as a primary diagnosis. The loss of sensation to defecate was reported by 13 (4.1%) and urinary related symptoms by 15 patients (4.7%) after operation.
Forty-eight patients (9.1%) had a reoperation; in 21 cases, this was performed because of a recurrence of ERP, giving an overall recurrence rate of 7.1% for ERP after LVMR. The reoperations are listed in Table 5 . In all, 215 (66%) of 328 respondents were subjectively satisfied with the LVMR results, 56 (17%) were dissatisfied, and 57 (17%) patients could not say.
Effects of Patient-Related and Operative Technical Details on Outcomes
Of all variables studied, better symptom relief was identified in patients with no previous pelvic operations (80.2%) compared with those who had undergone surgery before (68.1%; p = 0.016). However, the association disappeared in multivariate logistic regression models. According to the logistic regression models, >1 underlying disease was a negative predicting factor for symp- (Table 6 ).
DISCUSSION
Ventral mesh rectopexy has gained popularity in the treatment of ERP and symptomatic IRP. Our results showed LVMR to be safe and effective in treating pPFD with good patient satisfaction and low rates of recurrence and reoperation. The rates of complications and mesh-related problems were limited, and the number of de novo symptoms was acceptable. Of a set of several factors, we found that better symptom relief was more likely in patients with no previous pelvic operation and in patients undergoing an operation for ERP in comparison with patients with IRP. However, our study could not characterize more detailed patient-and operative technique-related factors predicting successful or nonsuccessful outcomes. The current study presents the third-largest material so far, consisting of 508 patients with the longest median follow-up of 44 months. 12, 14, 20 There is some heterogeneity in diagnostic and treatment protocols among the participating institutions, but as such the results reflect real-life policy. The cross-sectional nature of the study has several methodologic limitations. The disease-related severity scores were not routinely determined at each institution preoperatively during the evaluation period, and we only had information available about the preoperative incidences of symptoms. Therefore, VAS evaluation of the patient current symptom profile was used, reflecting the subjective experience of defecatory function for the patients. The subjective assessment of symptom relief in the VAS and the improvement seen in the ODS and Wexner scores in a subset of patients confirm that LVMR improves defecatory function of patients. In addition, a recall of symptoms retrospectively may be exposed to memory bias. The loss of patients to follow-up was notable, but a 71% response rate for the questionnaires should be considered acceptable. Long-term functional outcomes of larger cohorts have been published recently. 12, 14, 20 The recurrence rate of 7.1% for ERP and the need for reoperation in 6.1% of patients primarily operated on for IRP are in accordance with the literature. 20 Our results are also comparable with previous reports presenting improvements in incontinence in 70% to 90% and obstructed defecation in 60% to 80% of patients after LVMR. 8, 21 In addition to defecatory symptoms, the patients reported improvement in other pre-existing pelvic symptoms, although no specific symptom severity scores were used for their evaluation. Our findings also suggest a positive impact of LVMR on sexual function, as reported in previous studies. 12, 22 Patients with fecal incontinence associated with IRP or ERP have been reported to gain an equivalent benefit of LVMR, but reports on the appropriate treatment for obstructed defecation are conflicting. 23, 24 In our series, IRP patients with obstructed defecation symptoms showed the least satisfaction.
Type of complications n (%)
Undertaking surgical intervention for a benign disease calls for minimizing the risk of any adverse event. The overall complication rate of 11.4% is in accordance with previous studies reporting rates of 0% to 23.5%, 14 and most complications were minor. Although concerns have also been raised regarding potential mesh-related erosion, fistulation, dyspareunia, and stricturing after LVMR, the transabdominal route appears to be safer for rectovaginal septum reinforcement. 14, 25, 26 In the current study, mesh complications occurred in 1.4% of patients, which correlates with previously reported multicenter studies showing 1.3% to 2.0% mesh erosion rates. 14, 20 It is noteworthy that the most common mesh material used in our cohort was polyester, and although this has been associated with a significantly increased risk of mesh-erosion complications in some studies, 12, 14 in our analysis no specific mesh material could be identified as a risk factor. Stitch sinuses and perineotomy to correct low rectoceles have been associated previously with erosion problems. Our finding of perioperative vaginal perforation arising in 60% of patients facing later erosion complications confirms that mesh placement should be avoided in case of vaginal per- Change in preexisting pelvic organ prolapse symptoms FIGURE 1. Impact of operation on pelvic floor dysfunction. Severity of the symptoms was estimated by VAS from 0 to 100. Symptom-related discomfort was assessed from no discomfort to great discomfort. The impact of the operation and change in the symptoms was assessed from much worse to much better. ODS = obstructive defecation syndrome; QoL = quality of life; VAS = visual analog scale.
foration. 14, 20 We observed that adverse events seemed to have no effect on patient satisfaction or patient-reported outcomes in the long run.
Some of our findings are either new or inconsistent with the results of previous studies. De novo constipation and incontinence after ventral rectopexy have been demonstrated with incidences of 1.4% to 3.7% and 1.0% to 6.0%. 8, 12, 20, 27 In general, comprehensive analyses of newonset symptoms have not been surveyed previously or included in LVMR outcome reports. In all, 39% of the patients reported some new-onset symptoms after surgery; the urge to defecate was the most common, at 24.3%. Urge symptoms occurred more often after LVMR for IRP compared with ERP. The risk of urgency has been associated with stapled transanal rectal resections reducing the rectal ampulla volume, with a 1-year incidence of 26.8% in patients registered with the European stapled transanal rectal resection registry. 28 Unexpectedly, the incidence of postoperative urgency after LVMR in our study seemed to be similar. However, the true incidence and reasons for urgency arising after LVMR need additional research. Also, more profound prospective assessment to confirm and define our findings of the LVMR to urinary symptoms is necessary.
CONCLUSIONS
Ventral mesh rectopexy is an effective procedure for treating pPFD, exhibiting a low rate of complications and an acceptable rate of recurrence. Patient satisfaction and subjective improvements of defecatory symptoms are longlasting. In the long run, patients with ERP seem to benefit more from surgery than those with IRP associated with obstructed defecation symptoms. More studies are needed to identify predictive factors for successful and nonsuccessful operative results, with an emphasis on preoperative diagnostic findings and patient symptom profiles. Variables are reported as counts and (percentages). ERP = external rectal prolapse; IRP = internal rectal prolapse; LVMR = laparoscopic ventral mesh rectopexy; STARR = stapled transanal rectal resection; PPH = procedure for prolapse and hemorrhoids. 
